Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies

Bibliographic Details
Main Authors: Aram Avila-Herrera, Jeffrey A. Kimbrel, Jose Manuel Martí, James Thissen, Edwin A. Saada, Tracy Weisenberger, Kathryn T. Arrildt, Brent W. Segelke, Jonathan E. Allen, Adam Zemla, Monica K. Borucki
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810540/?tool=EBI
_version_ 1797341140791328768
author Aram Avila-Herrera
Jeffrey A. Kimbrel
Jose Manuel Martí
James Thissen
Edwin A. Saada
Tracy Weisenberger
Kathryn T. Arrildt
Brent W. Segelke
Jonathan E. Allen
Adam Zemla
Monica K. Borucki
author_facet Aram Avila-Herrera
Jeffrey A. Kimbrel
Jose Manuel Martí
James Thissen
Edwin A. Saada
Tracy Weisenberger
Kathryn T. Arrildt
Brent W. Segelke
Jonathan E. Allen
Adam Zemla
Monica K. Borucki
author_sort Aram Avila-Herrera
collection DOAJ
first_indexed 2024-03-08T10:13:24Z
format Article
id doaj.art-283b60b31d194f008d9dc05246724a1b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-08T10:13:24Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-283b60b31d194f008d9dc05246724a1b2024-01-29T05:31:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01191Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodiesAram Avila-HerreraJeffrey A. KimbrelJose Manuel MartíJames ThissenEdwin A. SaadaTracy WeisenbergerKathryn T. ArrildtBrent W. SegelkeJonathan E. AllenAdam ZemlaMonica K. Boruckihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810540/?tool=EBI
spellingShingle Aram Avila-Herrera
Jeffrey A. Kimbrel
Jose Manuel Martí
James Thissen
Edwin A. Saada
Tracy Weisenberger
Kathryn T. Arrildt
Brent W. Segelke
Jonathan E. Allen
Adam Zemla
Monica K. Borucki
Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
PLoS ONE
title Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
title_full Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
title_fullStr Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
title_full_unstemmed Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
title_short Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
title_sort differential laboratory passaging of sars cov 2 viral stocks impacts the in vitro assessment of neutralizing antibodies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10810540/?tool=EBI
work_keys_str_mv AT aramavilaherrera differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT jeffreyakimbrel differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT josemanuelmarti differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT jamesthissen differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT edwinasaada differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT tracyweisenberger differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT kathryntarrildt differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT brentwsegelke differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT jonathaneallen differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT adamzemla differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies
AT monicakborucki differentiallaboratorypassagingofsarscov2viralstocksimpactstheinvitroassessmentofneutralizingantibodies